Search
6-Chloropurine Riboside, 5'-Monophosphate
go.drugbank.com/drugs/DB03948ExperimentalSynonyms: 6-Chloropurine Riboside, 5'-Monophosphate5'-O-(L-Cysteinylsulfamoyl)adenosine
go.drugbank.com/drugs/DB02684ExperimentalSynonyms: 5'-O-(N-(L-Cysteinyl)-sulfamoyl)adenosine, 5'-O-(L-Cysteinylsulfamoyl)adenosine7-methyl-guanosine-5'-triphosphate
go.drugbank.com/drugs/DB02716ExperimentalSynonyms: 7-methyl-guanosine-5'-triphosphate, 7-methylguanosine 5'-(tetrahydrogen triphosphate)N-Pyridoxyl-Glycine-5-Monophosphate
go.drugbank.com/drugs/DB02824ExperimentalSynonyms: N-Pyridoxyl-Glycine-5-Monophosphate2,3-Dihydroxy-5-Oxo-Hexanedioate
go.drugbank.com/drugs/DB03237ExperimentalSynonyms: 2,3-Dihydroxy-5-Oxo-Hexanedioate8-Bromo-Adenosine-5'-Monophosphate
go.drugbank.com/drugs/DB03349ExperimentalSynonyms: 8-Bromo-Adenosine-5'-MonophosphateDeflazacort
go.drugbank.com/drugs/DB11921Approved[A179446,A179449,L6697] This disease usually manifests by muscle weakness in early childhood followed by loss of the ability to walk (ambulation) as early as age 7. … It is marketed by Marathon Pharmaceuticals and was approved in February 2017 by the FDA.
Synonyms: 11.BETA.,21-DIHYDROXY-2'-METHYL-5'.BETA.H-PREGNA-1,4-DIENO(17,16-D)OXAZOLE-3,20-DIONE 21-ACETATE, 5'H-PREGNA-1,4-DIENO(17,16-D)OXAZOLE-3,20-DIONE, 21-(ACETYLOXY)-11-HYDROXY-2'-METHYL-, (11.BETA.,16.BETA.)-Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A InducersEtripamil
go.drugbank.com/drugs/DB12605ApprovedInvestigational) to sinus rhythm in adults. … Etripamil is a nondihydropyridine, L-type calcium channel blocker.[A275238, L54728] It is a fast-acting drug with a short duration of action.
Categories: MATE 1 Inhibitors, P-glycoprotein inhibitorsSynonyms: Methyl 3-[2-[[(4S)-4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl]methylamino]ethyl]benzoate, Benzoic acid, 3-[2-[[(4S)-4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl]methylamino]ethyl]-, methyl esterBosutinib
go.drugbank.com/drugs/DB06616ApprovedInvestigationalPhiladelphia chromosome is a hallmark of CML due to the reciprocal translocation t(9;22)(q34;q11), resulting in a BCR-ABL fusion protein. … [A6902,A261796,A261801] The first BCR-ABL inhibitor, [imatinib], was introduced over a decade ago as a breakthrough in CML management; however, emerging resistance to [imatinib] poses challenges in achieving
Synonyms: 4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-3-quinolinecarbonitrileCategories: P-glycoprotein substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index